Research programme: mitochondrial protein modulators - Metabolic Solutions Development Company

Drug Profile

Research programme: mitochondrial protein modulators - Metabolic Solutions Development Company

Latest Information Update: 16 Jul 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Metabolic Solutions Development Company
  • Class Small molecules
  • Mechanism of Action Mitochondrial protein modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Cancer; Inflammation; Neurodegenerative disorders; Type 2 diabetes mellitus

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for research development in Type-2-diabetes-mellitus in USA (PO)
  • 02 Oct 2012 Pharmacodynamics data from a preclinical trial in Type-2 diabetes mellitus presented at the 48th Annual Meeting of the European Association for the Study of Diabetes (EASD-2012)
  • 13 Jun 2012 Metabolic Solutions Development Company's third-generation mitochondrial protein modulators do not appear to be available for licensing at this time
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top